EDN1 and ankylosing spondylitis: Increased ADMA levels suggest impaired nitric oxide metabolism in ankylosing spondylitis (AS) patients.Anti-TNF-α treatments showed beneficial effects on vascular function.No difference in ET-1 levels between AS patients and controls.